State Street Corp Cytokinetics Inc Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, State Street Corp holds 6,167,340 shares of CYTK stock, worth $264 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,167,340

Previous 6,458,324 4.51%

Holding current value

$264 Million

Previous $341 Million 14.92%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $13.5 Million - $17.1 Million	-290,984 Reduced 4.51%	6,167,340 $290 Million
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $4.62 Million - $5.43 Million	-90,212 Reduced 1.38%	6,458,324 $341 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $97.1 Million - $152 Million	2,028,178 Added 44.87%	6,548,536 $355 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $87.5 Million - $148 Million	-1,373,000 Reduced 23.3%	4,520,358 $317 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $16.6 Million - $51.7 Million	618,872 Added 11.73%	5,893,358 $492 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $5.39 Million - $6.7 Million	182,906 Added 3.59%	5,274,486 $155 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $11 Million - $13.8 Million	337,680 Added 7.1%	5,091,580 $166 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $9.71 Million - $13.3 Million	-291,014 Reduced 5.77%	4,753,900 $167 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $28.3 Million - $40.4 Million	789,789 Added 18.56%	5,044,914 $231 Million
Q3 2022 Nov 15, 2022	SELL	$38.54 - $54.52 $9.6 Million - $13.6 Million	-249,101 Reduced 5.53%	4,255,125 $206 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $10.4 Million - $15 Million	307,394 Added 7.32%	4,504,226 $177 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $6.29 Million - $9.73 Million	211,605 Added 5.31%	4,196,832 $154 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $11.2 Million - $15.1 Million	-325,061 Reduced 7.54%	3,985,227 $182 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $1.1 Million - $2.13 Million	59,502 Added 1.4%	4,310,288 $154 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $2.15 Million - $2.94 Million	108,816 Added 2.63%	4,250,786 $84.1 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $9.27 Million - $12.8 Million	-498,953 Reduced 10.75%	4,141,970 $96.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $13.1 Million - $24.6 Million	860,663 Added 22.77%	4,640,923 $96.4 Million
Q3 2020 Nov 10, 2020	BUY	$20.58 - $28.96 $15.2 Million - $21.4 Million	739,228 Added 24.31%	3,780,260 $81.8 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $3.96 Million - $8.76 Million	355,470 Added 13.24%	3,041,032 $71.7 Million
Q1 2020 May 11, 2020	BUY	$8.75 - $16.3 $23.5 Million - $43.8 Million	2,685,562 New	2,685,562 $31.7 Million

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

115M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.03B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cytokinetics Inc Transaction History